Primary prevention implantable cardioverter defibrillator (ICD) therapy in women-data from a multicenter French registry

Journal of the American Heart Association

Volumn 5, Issue 2, 2016, Pages

  Providência, Rui ^a,b   Marijon, Eloi ^c   Lambiase, Pier D ^b   Bouzeman, Abdeslam ^a   Defaye, Pascal ^d   Klug, Didier ^e   Amet, Denis ^c   Perier, Marie Cécile ^c,f   Gras, Daniel ^g   Algalarrondo, Vincent ^h   Deharo, Jean Claude ⁱ   Leclercq, Christophe ^j   Fauchier, Laurent ^k   Babuty, Dominique ^k   Bordachar, Pierre ^l   Sadoul, Nicolas ^m   Piot, Olivier ⁿ   Boveda, Serge ^a   Beganton, Frankie ^c  

^a CLINIQUE PASTEUR   (France)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HÔPITAL MICHALLON   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^g Nouvelles Cliniques Nantaises   (France)

^h HÔPITAL ANTOINE BÉCLÈRE   (France)

ⁱ TIMONE HOSPITAL   (France)

^j PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^k SERVICE DE DERMATOLOGIE   (France)

^l HAUT LÉVÊQUE HOSPITAL   (France)

^m CHU NANCY BRABOIS   (France)

ⁿ CENTRE CARDIOLOGIQUE DU NORD   (France)

more..

Author keywords

Death, sudden; Heart failure; Mortality; Shock

Indexed keywords

ADULT; ANEMIA; ARTICLE; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY SINUS LEAD PLACEMENT FAILURE; ECCHYMOSIS; FEMALE; FOLLOW UP; HEART TAMPONADE; HEMATOMA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INAPPROPRIATE SHOCK; ISCHEMIC CARDIOMYOPATHY; LEAD DISLODGMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MORTALITY; MULTICENTER STUDY; NERVE STIMULATION; NEW YORK HEART ASSOCIATION CLASS; NONISCHEMIC CARDIOMYOPATHY; PHRENIC NERVE STIMULATION; PNEUMOTHORAX; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS COMPLEX; RETROSPECTIVE STUDY; RISE OF THRESHOLD; SEPSIS; SEX DIFFERENCE; SHOCK; ADVERSE EFFECTS; AGED; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVERSION; CLINICAL TRIAL; COMPARATIVE STUDY; DEATH, SUDDEN, CARDIAC; DEVICES; FRANCE; HEALTH CARE DISPARITY; HEALTH DISPARITY; HEART FAILURE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTHESIS COMPLICATION; PROSTHESIS DESIGN; REGISTER; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FRANCE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85004129043     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002756     Document Type: Article

References (37)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882-1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
5. MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P, Birnie D, Simpson CS, Khaykin Y, Pinter A, Nanthakumar K, Calzavara AJ, Austin PC, Tu JV, Lee DS. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med. 2012;156:195-203.
6. van der Heijden AC, Thijssen J, Borleffs CJ, van Rees JB, H-oke U, van der Velde ET, van Erven T, Schalij MJ. Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients. Heart. 2013;99:1244-1249.
7. Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M; Israeli Working Group on Pacing and Electrophysiology. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli- ICD Registry. Europace. 2014;16:1175-1180.
8. Chauvin M, Frank R, Le Heuzey JY, Barnay C, Cazeau S, Djiane P, Guenoun M, Leenhardt A, Mabo P, Sadoul N; Groupes de stimulation cardiaque et de rythmologie de la Société française de cardiologie. Recommendations concernant l-implantation et la surveillance des défibrillateurs automatiques implantables. Arch Mal Coeur Vaiss. 2004;97:915-919.
9. Vandenbroucke JP. The making of strobe. Epidemiology. 2007;18:797-799.
10. Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, Santarelli P, Di Biase L, Natale A. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm. 2010;7:876-882.
11. Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol. 2008;22:65-70.
12. Gauri AJ, Davis A, Hont T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med. 2006;119:116.e17-116.e21.
13. Hernandez AF, Foranow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM, Peterson ED. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298:1525-1532.
14. Bhavnani SP, Pavuluri V, Coleman CI, Guertin D, Yarlagadda RK, Clyne CA, Kluger J. The gender-paradox among patients with implantable cardioverterdefibrillators: a propensity-matched study. Pacing Clin Electrophysiol. 2013;36:878-884.
15. Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE; MUSTT Investigators. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol. 2004;15:993-998.
16. Aronson D, Burger AJ. The effect of sex on ventricular arrhythmic events in patients with congestive heart failure. Pacing Clin Electrophysiol. 2002;25:1206-1211.
17. Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, Stampfer MJ, Manson JE. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107:2096-2101.
18. Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation. 1996;93:1170-1176.
19. Kannel WB, Wilson PW, D-Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136:205-212.
20. Haigney MC, Zareba W, Nasir JM, McNitt S, McAdams D, Gentlesk PJ, Goldstein RE, Moss AJ; MADIT II Investigators. Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm. 2009;6:180- 186.
21. Dash R, Frank KF, Carr AN, Moravec CS, Kranias EG. Gender influences on sarcoplasmic reticulum handling in failing human myocardium. J Mol Cell Cardiol. 2001;33:1345-1353.
22. Yarnoz MJ, Curtis AB. More reasons why men and women are not the same (gender differences in electrophysiology and arrhythmias). Am J Cardiol. 2008;101:1291-1296.
23. Larsen JA, Kadish AH. Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol. 1998;9:655-664.
24. Airaksinen KE, Ik Heimo MJ, Linnaluoto M, Tahvanainen KU, Huikuri HV. Gender difference in autonomic and hemodynamic reactions to abrupt coronary occlusion. J Am Coll Cardiol. 1998;31:301-306.
25. Albert CM, Nam EG, Rimm EB, Jin HW, Hajjar RJ, Hunter DJ, MacRae CA, Ellinor PT. Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation. 2008;117:16-23.
26. Newton-Cheh C, Cook NR, VanDenburgh M, Rimm EB, Ridker PM, Albert CM. A common variant at 9p21 is associated with sudden and arrhythmic cardiac death. Circulation. 2009;120:2062-2068.
27. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, West K, Kashuk C, Akyol M, Perz S, Jalilzadeh S, Illig T, Gieger C, Guo CY, Larson MG, Wichmann HE, Marbán E, O-Donnel CJ, Hirshhorn JN, K-a-ab S, Spooner PM, Meitinger T, Chakravarti A. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet. 2006;38:644-651.
28. Gavin MC, Newton-Cheh C, Gaziano JM, Cook NR, VanDenburgh M, Albert CM. A common variant in the b2-adrenergic receptor and risk of sudden cardiac death. Heart Rhythm. 2011;8:704-710.
29. Marijon E, Bougouin W, Périer MC, Celermajer DS, Jouven X. Incidence of sports-related sudden death in France by specific sports and sex. JAMA. 2013;310:642-643.
30. Marijon E, Bougouin W, Celermajer DS, Périer MC, Dumas F, Benameur N, Karam N, Lamhaut L, Tafflet M, Mustafic H, de Deus NM, Le Heuzey JY, Desnos M, Avillach P, Spaulding C, Cariou A, Prugger C, Empana JP, Jouven X. Characteristics and outcomes of sudden cardiac arrest during sports in women. Circ Arrhythm Electrophysiol. 2013;6:1185-1191.
31. Albert CM, Oh K, Whang W, Manson JE, Chae CU, Stampfer MJ, Willet WC, Hu FB. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation. 2005;112:3232-3238.
32. Arshad A, Moss AJ, Foster E, Padeletti L, Barsheshet A, Goldenberg I, Greenberg H, Hall WJ, McNitt S, Zareba W, Solomon S, Steinberg JS; MADITCRT Executive Committee. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol. 2011;57:813-820.
33. Crow RS, Hannan PJ, Folsom AR. Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence of absence of wide QRS complex: the ARIC study with 12 years of follow-up. Circulation. 2003;108:1985- 1989.
34. Russo AM, Day JD, Stolen K, Mullin CM, Doraiswamy V, Lerew DL, Olshansky B. Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial. J Cardiovasc Electrophysiol. 2009;20:973-978.
35. Russo AM, Daugherty SL, Masoudi FA, Wang Y, Curtis J, Lampert R. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: findings from the National Cardiovascular Data Registry (NCDR). Am Heart J. 2015;170:330-338.
36. Zabarovskaja S, Gadler F, Braunschweig F, St-ahlberg M, H-ornsten J, Linde C, Lund LH. Women have better long-term prognosis than men after cardiac resynchronization therapy. Europace. 2012;14:1148-1155.
37. Rho RW, Patton KK, Poole JE, Cleland JG, Shadman R, Anand I, Maggioni AP, Carson PE, Swedberg K, Levy WC. Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation. 2012;126:2402- 2407.